UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract TS2-1: The complexity of targeting PI3K for cancer therapy

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.TS2-1-TS2-1

Cantley, L

2019

Volltextzugriff (PDF)

Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial Cells

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (23), p.10992-11000

2005

Volltextzugriff (PDF)

Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Cancer research (Chicago, Ill.), 2013-07, Vol.73 (14), p.4429-4438

2013

Volltextzugriff (PDF)

Abstract SY12-01: PI 3-kinase and cancer metabolism

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.SY12-01-SY12-01

Cantley, Lewis C.

2016

Volltextzugriff (PDF)

Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma

Cancer research (Chicago, Ill.), 2022-07, Vol.82 (13), p.2403-2416

2022

Volltextzugriff (PDF)

Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain

Cancer research (Chicago, Ill.), 2015-02, Vol.75 (3), p.554-565

2015

Volltextzugriff (PDF)

Abstract MS1-1: Targeting PI3K

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.MS1-1-MS1-1

2012

Volltextzugriff (PDF)

Abstract 2062: Evaluating the effect of tumor necrosis on glycolytic flux and cell survival in glioblastoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2062-2062

2019

Volltextzugriff (PDF)

A Genetic Mouse Model of Invasive Endometrial Cancer Driven by Concurrent Loss of Pten and Lkb1 Is Highly Responsive to mTOR Inhibition

Cancer research (Chicago, Ill.), 2014-01, Vol.74 (1), p.15-23

2014

Volltextzugriff (PDF)

The Phosphoinositide 3-Kinase Regulatory Subunit p85α Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor Signaling

Cancer research (Chicago, Ill.), 2010-07, Vol.70 (13), p.5305-5315

2010

Volltextzugriff (PDF)

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission

Cancer research (Chicago, Ill.), 2022-11, Vol.82 (21), p.3861-3867

2022

Volltextzugriff (PDF)

Abstract IA22: PI3K and cancer metabolism

Cancer research (Chicago, Ill.), 2013-10, Vol.73 (19_Supplement), p.IA22-IA22

Cantley, Lewis C.

2013

Volltextzugriff (PDF)

Abstract 159: Analysis of resistance to the combination of a PI3K- and Parp-inhibitor using a genomic sequencing approach

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.159-159

2016

Volltextzugriff (PDF)

Abstract SY34-01: Biomarkers for predicting response to PI3K inhibitors

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.SY34-01-SY34-01

Cantley, Lewis C.

2011

Volltextzugriff (PDF)

Abstract A072: Decoding human kinome specificities through a computational data-driven approach and unveiling kinase activity in pancreatic ductal adenocarcinoma

Cancer research (Chicago, Ill.), 2024-09, Vol.84 (17_Supplement_2), p.A072-A072

2024

Volltextzugriff (PDF)

Abstract 4165: Myc vs. Akt therapy in RapidCap, a GEM model for metastatic prostate cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4165-4165

2016

Volltextzugriff (PDF)

Abstract GS6-06: A neoadjuvant trial with letrozole identifies PRR11 in the 17q23 amplicon as a mechanism of resistance to endocrine therapy in ER-positive breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.GS6-06-GS6-06

2020

Volltextzugriff (PDF)

Abstract 16: Patterns and regulation of post translational modifications in cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.16-16

2021

Volltextzugriff (PDF)

Abstract A078: Towards understanding noncanonical phosphatidylinositol kinases in the maintenance of prostate metabolism

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (16_Supplement), p.A078-A078

2018

Volltextzugriff (PDF)

Abstract IA-2: PI3-Kinase and cancer metabolism

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (23_Supplement), p.IA-2-IA-2

Cantley, Lewis C.

2009

Volltextzugriff (PDF)

Using Tandem Mass Spectrometry in Targeted Mode to Identify Activators of Class IA PI3K in Cancer

Cancer research (Chicago, Ill.), 2011-09, Vol.71 (18), p.5965-5975

2011

Volltextzugriff (PDF)

Abstract 3858: Feasibility and efficacy of a precision treatment approach for triple-negative breast cancer in mouse models

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3858-3858

2016

Volltextzugriff (PDF)

Abstract 1625: CUB domain-containing protein 1 (CDCP1) promotes metastatic phenotype in pancreatic ductal adenocarcinoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1625-1625

2016

Volltextzugriff (PDF)

Abstract NG16: Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.NG16-NG16

2020

Volltextzugriff (PDF)

Abstract 5687: Selective, chemically-induced degradation of BRM ( SMARCA2 ) enables in vivo efficacy in BRG1 ( SMARCA4 )-deficient xenograft tumor models

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5687-5687

2020

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(74)

Sprache

Englisch
(74)

Erscheinungsjahr

n.n

Kollektion

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Abstract TS2-1: The complexity of targeting PI3K for cancer therapy

Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial Cells

Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Abstract SY12-01: PI 3-kinase and cancer metabolism

Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma

Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain

Abstract MS1-1: Targeting PI3K

Abstract 2062: Evaluating the effect of tumor necrosis on glycolytic flux and cell survival in glioblastoma

A Genetic Mouse Model of Invasive Endometrial Cancer Driven by Concurrent Loss of Pten and Lkb1 Is Highly Responsive to mTOR Inhibition

The Phosphoinositide 3-Kinase Regulatory Subunit p85α Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor Signaling

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission

Abstract IA22: PI3K and cancer metabolism

Abstract 159: Analysis of resistance to the combination of a PI3K- and Parp-inhibitor using a genomic sequencing approach

Abstract SY34-01: Biomarkers for predicting response to PI3K inhibitors

Abstract A072: Decoding human kinome specificities through a computational data-driven approach and unveiling kinase activity in pancreatic ductal adenocarcinoma

Abstract 4165: Myc vs. Akt therapy in RapidCap, a GEM model for metastatic prostate cancer

Abstract GS6-06: A neoadjuvant trial with letrozole identifies PRR11 in the 17q23 amplicon as a mechanism of resistance to endocrine therapy in ER-positive breast cancer

Abstract 16: Patterns and regulation of post translational modifications in cancer

Abstract A078: Towards understanding noncanonical phosphatidylinositol kinases in the maintenance of prostate metabolism

Abstract IA-2: PI3-Kinase and cancer metabolism

Using Tandem Mass Spectrometry in Targeted Mode to Identify Activators of Class IA PI3K in Cancer

Abstract 3858: Feasibility and efficacy of a precision treatment approach for triple-negative breast cancer in mouse models

Abstract 1625: CUB domain-containing protein 1 (CDCP1) promotes metastatic phenotype in pancreatic ductal adenocarcinoma

Abstract NG16: Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors

Abstract 5687: Selective, chemically-induced degradation of BRM ( SMARCA2 ) enables in vivo efficacy in BRG1 ( SMARCA4 )-deficient xenograft tumor models

Aktive Filter

Suchergebnisse filtern